Stock Predictor

An insider is legally permitted to buy and sell shares of the firm – and any subsidiaries – that employs him or her. However, these transactions must be properly registered with the Securities and Exchange Commission (SEC) and are done with advance filings. You can find details of this type of insider trading on the SEC’s EDGAR database. This algorithmic forecast is for stocks with recently reported insiders’ transactions.An “insider” is any person who possesses at least one of the following:

• access to valuable non-public information about a corporation (for example a company’s directors and high-level executives)
• ownership of more than 10% of the company’s equity

Package Name: Insiders Stocks
Recommended Positions: Long
Forecast Length: 1 Month (11/10/2017 – 12/10/2017)
I Know First Average: 12.80%

The algorithm correctly predicted 8 out 10 of the suggested trades in the Insiders Stocks Package for this 1 Month forecast. NKTR was the highest-earning trade with a return of 70.04% in 1 Month. Additional high returns came from FSLR and NSP, at 15.66% and 12.18% respectively. The package had an overall average return of 12.80%, providing investors with a 10.21% premium over the S&P 500’s return of 2.59% during the period.

Nektar Therapeutics (NKTR), develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.